Lei Deng

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Topics

Randomized Controlled Trial

Small Cell Lung Cancer

Top Venues

Thoracic cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Lei Deng, Gulidanna Shayan, Wei Jiang, Nan Bi, Luhua Wang
Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive-stage small cell lung cancer (ES-SCLC): Study protocol. Thoracic cancer 15 (11) (2024)
Lei Deng, Gulidanna Shayan, Wei Jiang, Nan Bi, Luhua Wang
Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive-stage small cell lung cancer (ES-SCLC): Study protocol. Thoracic cancer 15 (11) (2024)
Lei Deng, Gulidanna Shayan, Wei Jiang, Nan Bi, Luhua Wang
Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive-stage small cell lung cancer (ES-SCLC): Study protocol. Thoracic cancer (2024)
Lei Deng, Gulidanna Shayan, Wei Jiang, Nan Bi, Luhua Wang
Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive-stage small cell lung cancer (ES-SCLC): Study protocol. Thoracic cancer 15 (11) (2024)
Lei Deng, Gulidanna Shayan, Wei Jiang, Nan Bi, Luhua Wang
Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive-stage small cell lung cancer (ES-SCLC): Study protocol. Thoracic cancer 15 (11) (2024)
Lei Deng, Gulidanna Shayan, Wei Jiang, Nan Bi, Luhua Wang
Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive-stage small cell lung cancer (ES-SCLC): Study protocol. Thoracic cancer 15 (11) (2024)
Zeliang Ma, Bin Liang, Ran Wei, Yunsong Liu, Yongxing Bao, Meng Yuan, Yu Men, Jianyang Wang, Lei Deng, Yirui Zhai, Nan Bi, Luhua Wang, Jianrong Dai, Zhouguang Hui
Enhanced prediction of postoperative radiotherapy-induced esophagitis in non-small cell lung cancer: Dosiomic model development in a real-world cohort and validation in the PORT-C randomized controlled trial. Thoracic cancer (2023)
Chanjuan Cui, Xi Wu, Lei Deng, Wenqing Wang, Wei Cui, Yanfeng Wang
Modified Glasgow prognostic score predicts the prognosis of patients with advanced esophageal squamous cell carcinoma: A propensity score-matched analysis. Thoracic cancer 13 (14) (2022)
Yanfeng Wang, Chanjuan Cui, Xin Liu, Lei Deng, Ke Yang, Bin Li, Jie Xue, Junying Xie, Wei Cui
Conditional catheter-related thrombosis free probability and risk-adapted choices of catheter for lung cancer. Thoracic cancer 13 (12) (2022)
Yufan Yang, Tao Zhang, Zongmei Zhou, Jun Liang, Dongfu Chen, Qin-Fu Feng, Zefen Xiao, Zhouguang Hui, Jima Lv, Lei Deng, Xin Wang, Wenqing Wang, Jianyang Wang, Wenyang Liu, Yirui Zhai, Jie Wang, Nan Bi, Luhua Wang
Development and validation of a prediction model using molecular marker for long-term survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy. Thoracic cancer 13 (3) (2021)
Kunpeng Xu, Jun Liang, Tao Zhang, Zongmei Zhou, Dongfu Chen, Qin-Fu Feng, Zefen Xiao, Zhouguang Hui, Jima Lu, Xin Wang, Lei Deng, Wenyang Liu, Jianyang Wang, Yirui Zhai, Jie Wang, Nan Bi, Luhua Wang
Clinical outcomes and radiation pneumonitis after concurrent EGFR-tyrosine kinase inhibitors and radiotherapy for unresectable stage III non-small cell lung cancer. Thoracic cancer 12 (6) (2021)
Chen Li, Lijun Tan, Xiao Liu, Xin Wang, Zongmei Zhou, Dongfu Chen, Qinfu Feng, Jun Liang, Jima Lv, Xiaozhen Wang, Nan Bi, Lei Deng, Wenqing Wang, Tao Zhang, Wenjie Ni, Xiao Chang, Weiming Han, Linrui Gao, Shijia Wang, Zefen Xiao
Concurrent chemoradiotherapy versus radiotherapy alone for patients with locally advanced esophageal squamous cell carcinoma in the era of intensity modulated radiotherapy: a propensity score-matched analysis. Thoracic cancer 12 (12) (2021)
Meng Yuan, Yirui Zhai, Yu Men, Jianyang Wang, Lei Deng, Wenqing Wang, Yongxing Bao, Xu Yang, Shuang Sun, Zeliang Ma, Yunsong Liu, Jianing Wang, Hui Zhu, Zhouguang Hui
Endostar (rh-endostatin) improves efficacy of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer: A systematic review and meta-analysis. Thoracic cancer 12 (23) (2021)
Meng Yuan, Yu Men, Jingjing Kang, Xin Sun, Maoyuan Zhao, Yongxing Bao, Xu Yang, Shuang Sun, Zeliang Ma, Jianyang Wang, Lei Deng, Wenqing Wang, Yirui Zhai, Wenyang Liu, Tao Zhang, Xin Wang, Nan Bi, Jima Lv, Jun Liang, Qinfu Feng, Dongfu Chen, Zefen Xiao, Zongmei Zhou, Luhua Wang, Zhouguang Hui
Postoperative radiotherapy for pathological stage IIIA-N2 non-small cell lung cancer with positive surgical margins. Thoracic cancer 12 (2) (2020)
Tao Zhang, Kunpeng Xu, Nan Bi, Li Zhang, Wei Jiang, Jun Liang, Lei Deng, Xin Wang, Jianyang Wang, Jie Wang, Luhua Wang
Efficacy and safety of immune checkpoint inhibitor consolidation after chemoradiation in patients of Asian ethnicity with unresectable stage III non-small cell lung cancer: Chinese multicenter report and literature review. Thoracic cancer 11 (10) (2020)
Lei Deng, ZongMei Zhou, ZeFen Xiao, DongFu Chen, QinFu Feng, Jun Liang, JiMa Lv, XiaoZhen Wang, Nan Bi, Xin Wang, Tao Zhang, WenQing Wang, LvHua Wang
Impact of thoracic radiation therapy after chemotherapy on survival in extensive-stage small cell lung cancer: A propensity score-matched analysis. Thoracic cancer 10 (4) (2019)